There are a lot of reasons to set up shop in Germany, if you’ve got a medical biotechnology business. It’s the center of the sector in Europe and at the heart of the industry worldwide, as our new video discusses.
32 search results for: medical biotech
In 2018, 36 of the 65 newly approved medications in Germany were biopharmaceuticals – an unprecedented fifty-eight percent.
Israel’s Kidod Science & Technologies has joined the eastern German city’s Health + IT Campus.
As Europe’s largest medical biotech market, Germany continues to attract foreign investment thanks to its many established companies and dynamic start-up sector. Gradian Diagnostics’ recent acquisition of Molzym is a fine example of international matchmaking, facilitated by Germany Trade & Invest.
German biotech continues to grow, representing an opportunity for foreign capital.
Germany is Europe’s number one healthcare market by volume: Patients, manufacturers and providers power a life science industry composed of thriving medical technology, pharmaceuticals, medical biotechnology, and digital health sectors.
Germany’s single-cell biotechnology sector is transforming cancer treatments by shining a light on the genetic activity of individual cells. It’s also advancing our understanding of how our immune defences respond to Covid-19.
Throughout 2021, this website featured more than 330 articles and videos about Germany as a business and high-tech location. Below is a list so that you can catch up on anything you might have missed.
Industrial electromobility picks up the pace in Saxony-Anhalt.
Over the past decade, healthtech startups in the Bavarian capital have taken in just under EUR 968 million in financing – that’s according to information compiled by the website Munich Startup in its Data & Insights Dashboard.
If you are not happy with the results below please do another search